0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Breast Cancer
 41-60 of 742 Articles
JAMA Oncology | 
Original Investigation | 
Mark Clemons, MD; Nathaniel Bouganim, MD; Stephanie Smith, BA; et al.
JAMA Oncol. 2016;2(2):225-231. doi:10.1001/jamaoncol.2015.3730.
Includes: Supplemental Content

JAMA Oncology | 
Editorial | 
Jee Ye Kim, MD; Seung-il Kim, MD, PhD; Soonmyung Paik, MD
JAMA Oncol. 2016;2(2):180-182. doi:10.1001/jamaoncol.2015.4343.

JAMA Oncology | 
Original Investigation | 
Shelli R. Kesler, PhD; Douglas W. Blayney, MD
JAMA Oncol. 2016;2(2):185-192. doi:10.1001/jamaoncol.2015.4333.
Includes: Supplemental Content

JAMA Oncology | 
Original Investigation | 
Michail Ignatiadis, MD, PhD; Hatem A. Azim Jr, MD, PhD; Christine Desmedt, PhD; et al.
JAMA Oncol. 2016;2(2):217-224. doi:10.1001/jamaoncol.2015.4377.
Includes: Supplemental Content

JAMA Oncology | 
Review | 
Amy S. Clark, MD, MSCE; Thomas B. Karasic, MD; Angela DeMichele, MD, MSCE; et al.
JAMA Oncol. 2016;2(2):253-260. doi:10.1001/jamaoncol.2015.4701.
Includes: CME, Supplemental Content

JAMA Oncology | 
Brief Report | 
Jashodeep Datta, MD; Megan Fracol, MD; Matthew T. McMillan, BA; et al.
JAMA Oncol. 2016;2(2):242-246. doi:10.1001/jamaoncol.2015.5482.
Includes: Supplemental Content

JAMA Oncology | 
From The JAMA Network | 
Michael LeBlanc, PhD; Catherine Tangen, DrPH
JAMA Oncol. 2016;2(2):263-264. doi:10.1001/jamaoncol.2015.4711.

JAMA Oncology | 
From The JAMA Network | 
Heidi D. Nelson, MD, MPH
JAMA Oncol. 2016;2(2):261-262. doi:10.1001/jamaoncol.2015.4096.

JAMA | 
News From the Food and Drug Administration | 
Rebecca Voelker, MSJ
JAMA. 2016;315(3):243. doi:10.1001/jama.2015.18375.

JAMA | 
News From the Centers for Disease Control and Prevention | 
JAMA. 2016;315(2):123. doi:10.1001/jama.2015.17834.

JAMA | 
Original Investigation | 
Lorelei A. Mucci, ScD, MPH; Jacob B. Hjelmborg, PhD; Jennifer R. Harris, PhD; et al.
JAMA. 2016;315(1):68-76. doi:10.1001/jama.2015.17703.
Includes: CME, Supplemental Content

JAMA Oncology | 
Editorial | 
Sylvia Adams, MD, MS
JAMA Oncol. 2016;2(1):25-27. doi:10.1001/jamaoncol.2015.3236.

JAMA Oncology | 
Original Investigation | 
Edith A. Perez, MD; Karla V. Ballman, PhD; Kathy S. Tenner, BS; et al.
JAMA Oncol. 2016;2(1):56-64. doi:10.1001/jamaoncol.2015.3239.
Includes: Supplemental Content

JAMA Oncology | 
Editorial | 
Gérard Milano, PhD; Emmanuel Chamorey, PharmD, PhD; Jean-Marc Ferrero, MD, PhD
JAMA Oncol. 2016;2(1):21-22. doi:10.1001/jamaoncol.2015.3866.

JAMA Oncology | 
Invited Commentary | 
Abram Recht, MD
JAMA Oncol. 2016;2(1):102-103. doi:10.1001/jamaoncol.2015.3826.

JAMA Oncology | 
Original Investigation | 
Chau Dang, MD; Hao Guo, MS; Julie Najita, PhD; et al.
JAMA Oncol. 2016;2(1):29-36. doi:10.1001/jamaoncol.2015.3709.
Includes: Supplemental Content

JAMA Oncology | 
Original Investigation | 
Lane L. Frasier, MD; Sara Holden, MD; Timothy Holden, MD, MS; et al.
JAMA Oncol. 2016;2(1):95-101. doi:10.1001/jamaoncol.2015.3717.

JAMA Oncology | 
Invited Commentary | 
Kutluk Oktay, MD, PhD; Volkan Turan, MD
JAMA Oncol. 2016;2(1):74-75. doi:10.1001/jamaoncol.2015.3252.
Includes: Supplemental Content

JAMA Oncology | 
Original Investigation | 
Rodrigo R. Munhoz, MD; Allan A. L. Pereira, MD; André D. Sasse, MD; et al.
JAMA Oncol. 2016;2(1):65-73. doi:10.1001/jamaoncol.2015.3251.
Includes: CME

JAMA | 
Editorial | 
Ann H. Partridge, MD, MPH
JAMA. 2015;314(24):2625-2627. doi:10.1001/jama.2015.17299.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA
Research Letter  | 
Breast Cancer Screening Using Tomosynthesis and Digital Mammography in Dense and Nondense Breasts
Elizabeth A. Rafferty, MD; Melissa A. Durand, MD; Emily F. Conant, MD; et al.
JAMA Oncology
Invited Commentary  | 
Adjuvant Trastuzumab Benefit in Patients Diagnosed With Triple-Positive Breast Cancer
Anne F. Schott, MD
JAMA Oncology
Research Letter  | 
Comparison of Neurocognitive Function After Anthracycline-Based Chemotherapy vs Nonanthracycline-Based Chemotherapy
Kathleen Van Dyk, PhD; Laura Petersen, MS; Patricia A. Ganz, MD
JAMA Oncology
Original Investigation  | 
Effects of Estrogen Receptor and Human Epidermal Growth Factor Receptor-2 Levels on the Efficacy of Trastuzumab A Secondary Analysis of the HERA Trial
Sherene Loi, MD, PhD; Urania Dafni, ScD; Dimitris Karlis, PhD; et al.